Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus
Jan Hagemann, Gabrielle L. Onorato, Marek Jutel, et al.
Allergy (2021) Vol. 76, Iss. 8, pp. 2354-2366
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 225
Update on pathomechanisms and treatments in allergic rhinitis
Yuan Zhang, Feng Lan, Luo Zhang
Allergy (2022) Vol. 77, Iss. 11, pp. 3309-3319
Closed Access | Times Cited: 94
A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
Kathrin Ohla, Maria G. Veldhuizen, T. Green, et al.
Rhinology Journal (2022)
Open Access | Times Cited: 75
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 70
La literatura en la educación médica
Herlinda Dabbah Mustri
(2023) Vol. 1, Iss. 1
Open Access | Times Cited: 27
Paulina Rivero Weber y su mirada filosófica en torno a la bioética
Jonathan Caudillo Lozano
(2023) Vol. 1, Iss. 1
Open Access | Times Cited: 27


(2023) Vol. 1, Iss. 1
Open Access | Times Cited: 27
Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study
Eugene Merzon, Margaret D. Weiss, Beth Krone, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 10, pp. 5993-5993
Open Access | Times Cited: 36
Olfactory and gustatory disorders in COVID-19
Ludger Klimek, Jan Hagemann, Julia Döge, et al.
Allergo Journal International (2022) Vol. 31, Iss. 7, pp. 243-250
Open Access | Times Cited: 31
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39
Depressive Symptoms Among Children and Adolescents in China During the Coronavirus Disease-19 Epidemic: A Systematic Review and Meta-Analysis
Jianghe Chen, Kun Yang, Yujia Cao, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 23
Interplay Between COVID- 19 and Chronic Rhinosinusitis: Clinical Insights
Yuxin Zhou, Li Pan, Xianghong Wang, et al.
Current Treatment Options in Allergy (2025) Vol. 12, Iss. 1
Closed Access
Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)
Ludger Klimek, Jan Hagemann, Thomas Hummel, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 6, pp. 100653-100653
Open Access | Times Cited: 18
Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2—results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)
Constantin A. Hintschich, Veronika Vielsmeier, Christopher Bohr, et al.
European Archives of Oto-Rhino-Laryngology (2022) Vol. 279, Iss. 11, pp. 5445-5447
Open Access | Times Cited: 16
Increasing incidence of parosmia and phantosmia in patients recovering from COVID-19 smell loss
Kathrin Ohla, Maria G. Veldhuizen, Tomer Green, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases
Jan Gutermuth, Martine Grosber, Oliver Pfaar, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 248-258
Open Access | Times Cited: 11
Reshaping the Management of Allergic Rhinitis in Primary Care: Lessons from the COVID-19 Pandemic
Baharudin Abdullah, Kornkiat Snidvongs, Niken Lestari Poerbonegoro, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13632-13632
Open Access | Times Cited: 8
Global expert views on the diagnosis, classification and pharmacotherapy of allergic rhinitis in clinical practice using a modified Delphi panel technique
Désirée Larenas‐Linnemann, José L. Mayorga-Butrón, Juan M. Solano, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 7, pp. 100800-100800
Open Access | Times Cited: 4
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?
Ludger Klimek, Jan Hagemann, Tilman Huppertz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1399-1406
Closed Access | Times Cited: 4
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
Allergologie select (2021) Vol. 5, Iss. 01, pp. 251-259
Open Access | Times Cited: 10
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19
Can Tüzer, Pelin Karadağ, Osman Ozan Yeğit, et al.
Allergy and Asthma Proceedings (2022) Vol. 43, Iss. 2, pp. 106-115
Open Access | Times Cited: 7
Rhinology in review: from COVID-19 to biologicals
Wytske J. Fokkens, Basile N. Landis, Claire Hopkins, et al.
Rhinology Journal (2021)
Closed Access | Times Cited: 9
Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022
Olga Lourenço, Biljana Cvetkovski, Vicky Kritikos, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 6
An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding
Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Correspondence to “Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus”
Peter Smith, Olivia Lesslar, David Price
Allergy (2022) Vol. 77, Iss. 8, pp. 2571-2573
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top